Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice

Journal of Neurochemistry
Ibrahim KayaJohn S Fletcher

Abstract

There is emerging evidence that amyloid beta (Aβ) aggregates forming neuritic plaques lead to impairment of the lipid-rich myelin sheath and glia. In this study, we examined focal myelin lipid alterations and the disruption of the myelin sheath associated with amyloid plaques in a widely used familial Alzheimer's disease (AD) mouse model; 5xFAD. This AD mouse model has Aβ42 peptide-rich plaque deposition in the brain parenchyma. Matrix-assisted laser desorption/ionization imaging mass spectrometry of coronal brain tissue sections revealed focal Aβ plaque-associated depletion of multiple myelin-associated lipid species including sulfatides, galactosylceramides, and specific plasmalogen phopshatidylethanolamines in the hippocampus, cortex, and on the edges of corpus callosum. Certain phosphatidylcholines abundant in myelin were also depleted in amyloid plaques on the edges of corpus callosum. Further, lysophosphatidylethanolamines and lysophosphatidylcholines, implicated in neuroinflammation, were found to accumulate in amyloid plaques. Double staining of the consecutive sections with fluoromyelin and amyloid-specific antibody revealed amyloid plaque-associated myelin sheath disruption on the edges of the corpus callosum which is...Continue Reading

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
Jan 1, 1988·Acta Neuropathologica·G AlltK Sikri
Oct 1, 1973·Journal of Neurochemistry·W T Norton, S E Poduslo
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jun 14, 1996·Neuroscience Letters·M NakaiC Tanaka
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K R BalesS M Paul
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Nov 21, 2002·Analytical Biochemistry·Markus StoeckliLuca Signor
Dec 27, 2002·The Journal of Biological Chemistry·Xianlin HanDavid M Holtzman
Nov 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pascale N LacorWilliam L Klein
Oct 18, 2005·Nature Cell Biology·Marcus O W GrimmTobias Hartmann
Apr 21, 2006·The FEBS Journal·Giorgis IsaacJan-Eric Månsson
May 2, 2007·Mass Spectrometry Reviews·Liam A McDonnell, Ron M A Heeren
Sep 25, 2007·Neurobiology of Aging·Veera Venkata Ratnam BandaruNorman J Haughey
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
Mar 4, 2010·Acta Neuropathologica·Stanislaw MitewTracey C Dickson
May 18, 2010·Biochimica Et Biophysica Acta·Paul Foley
Aug 11, 2010·The American Journal of Pathology·Maya K DesaiWilliam J Bowers
Feb 8, 2011·Journal of Alzheimer's Disease : JAD·Miki IgarashiJagadeesh S Rao
Mar 31, 2011·Nature Reviews. Neuroscience·Gilbert Di Paolo, Tae-Wan Kim
May 20, 2011·Acta Neuropathologica·Jianqiu KouJohannes Berger
Sep 29, 2011·Chemical Reviews·Karin A Zemski BerryRobert C Murphy
Jul 25, 2012·Annals of the New York Academy of Sciences·Toshihiko KatafuchiTakehiko Fujino
Apr 18, 2013·ACS Chemical Neuroscience·Amina S WoodsCarey Balaban
Sep 18, 2013·Neurobiology of Aging·Luke WhileyUNKNOWN AddNeuroMed Consortium

❮ Previous
Next ❯

Citations

Oct 14, 2020·Journal of Neurochemistry·Martina Blank, Carsten Hopf
Jun 8, 2021·Journal of Alzheimer's Disease : JAD·Johan SvenssonAnders Wallin

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.